ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,282.70
      0.13%
      US Tech 100
      17,825.60
      0.33%
      Dow Jones
      39,142.23
      -1.33%
      Brent Oil
      67.075
      0.00%
      Bitcoin
      85,177.09
      0.82%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Vor Biopharma Inc (VOR) Quote

      Vor Biopharma Inc

      Vor Biopharma Inc (VOR)

      Vortiv Limited
      0.65
      0.00
      (0.00%)
      Closed April 19 4:00PM
      Delayed by 15 minutes
      0.65
      0.006
      (0.93%)
      After Hours: 7:04PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.65
      Bid
      0.6227
      Ask
      0.6995
      Volume
      121,866
      0.63 Day's Range 0.6994
      0.49 52 Week Range 1.95
      Market Cap
      81.154M
      Previous Close
      0.65
      Open
      0.6511
      Last Trade
      45
      @
      0.6825
      Last Trade Time
      Financial Volume
      $ 79,385
      VWAP
      0.651414
      Average Volume (3m)
      327,095
      Shares Outstanding
      124,851,547
      Dividend Yield
      -
      PE Ratio
      -0.68
      Earnings Per Share (EPS)
      -0.94
      Revenue
      -
      Net Profit
      -116.91M

      About Vor Biopharma Inc

      Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.vorbio.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Vor Biopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker VOR. The last closing price for Vor Biopharma was $0.65. Over the last year, Vor Biopharma shares have traded in a share price range of $ 0.49 to $ 1.95.

      Vor Biopharma currently has 124,851,547 shares outstanding. The market capitalization of Vor Biopharma is $81.15 million. Vor Biopharma has a price to earnings ratio (PE ratio) of -0.68.

      Ask ADVFN Intelligence (AI)

      VOR Latest News

      More News

      Form ARS - Annual Report to Security Holders
      Edgar (US Regulatory)
      April 08 2025
      VOR (0.00%)

      Form DEF 14A - Other definitive proxy statements
      Edgar (US Regulatory)
      April 08 2025
      VOR (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      April 03 2025
      VOR (0.00%)

      Form EFFECT - Notice of Effectiveness
      Edgar (US Regulatory)
      April 01 2025
      VOR (0.00%)

      Form PRE 14A - Other preliminary proxy statements
      Edgar (US Regulatory)
      March 28 2025
      VOR (0.00%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      March 20 2025
      VOR (0.00%)

      Form S-3 - Registration statement under Securities Act of 1933
      Edgar (US Regulatory)
      March 20 2025
      VOR (0.00%)

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      Edgar (US Regulatory)
      March 20 2025
      VOR (0.00%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.01722.71807838180.63280.74550.581750620.67252215CS
      4-0.193-22.89442467380.8430.920.492407380.68470715CS
      12-0.94-59.11949685531.591.590.493270951.08778044CS
      26-0.04-5.797101449280.691.80.495441661.10069139CS
      52-1.06-61.98830409361.711.950.495654931.05224758CS
      156-5.12-88.73483535535.777.570.492984102.08406953CS
      260-41.37-98.453117563142.0263.620.492554705.65381317CS

      VOR - Frequently Asked Questions (FAQ)

      What is the current Vor Biopharma share price?
      The current share price of Vor Biopharma is $ 0.65
      How many Vor Biopharma shares are in issue?
      Vor Biopharma has 124,851,547 shares in issue
      What is the market cap of Vor Biopharma?
      The market capitalisation of Vor Biopharma is USD 81.15M
      What is the 1 year trading range for Vor Biopharma share price?
      Vor Biopharma has traded in the range of $ 0.49 to $ 1.95 during the past year
      What is the PE ratio of Vor Biopharma?
      The price to earnings ratio of Vor Biopharma is -0.68
      What is the reporting currency for Vor Biopharma?
      Vor Biopharma reports financial results in USD
      What is the latest annual profit for Vor Biopharma?
      The latest annual profit of Vor Biopharma is USD -116.91M
      What is the registered address of Vor Biopharma?
      The registered address for Vor Biopharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Vor Biopharma website address?
      The website address for Vor Biopharma is www.vorbio.com
      Which industry sector does Vor Biopharma operate in?
      Vor Biopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MSGMMotorsport Games Inc
      $ 2.69
      (140.18%)
      		37M
      SXTCChina SXT Pharmaceuticals Inc
      $ 2.11
      (113.37%)
      		51.73M
      ADGMAdagio Medical Holdings Inc
      $ 1.68
      (81.98%)
      		115.48M
      PNBKPatriot National Bancorp Inc
      $ 3.28
      (73.54%)
      		1.57M
      RTCBaijiayun Group Ltd
      $ 0.3601
      (67.49%)
      		187.02M
      LXEHLixiang Education Holding Company Ltd
      $ 8.25
      (-64.11%)
      		1.55M
      CLIKClick Holdings Ltd
      $ 0.355
      (-48.18%)
      		13.52M
      IOTRiOThree Ltd
      $ 1.1409
      (-38.33%)
      		3.93M
      FMTOFemto Technologies Inc
      $ 0.0191
      (-35.47%)
      		198.4M
      SISIShineco Inc
      $ 0.5809
      (-35.07%)
      		824.91k
      DMNDamon Inc
      $ 0.0034
      (9.68%)
      		409.39M
      STSSSharps Technology Inc
      $ 0.03195
      (20.57%)
      		391.8M
      SUNESUNation Energy Inc
      $ 0.0176
      (-10.20%)
      		349.4M
      NVDANVIDIA Corporation
      $ 101.49
      (-2.87%)
      		292.48M
      HTZHertz Global Holdings Inc
      $ 8.205
      (43.70%)
      		266.91M

      VOR Discussion

      View Posts
      PonkenPlonken PonkenPlonken 3 months ago
      theres this board Biotech Values - they will one up each other on how much the 16th drug in Pfizers portfolio will generate in sales 2025 but never look at anything like this?
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      zipline all day
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      not letting up
      👍️0
      Monksdream Monksdream 4 months ago
      VOR, ten day hourly
      👍️ 1
      Monksdream Monksdream 4 months ago
      So it’s a CRSPR stock
      Certainly when Jennifer Doudna and Emanelle Charpentier who won the 2020 chemistry Nobel wanted to share their discovery
      Gene editing in many respects remains in the R&D stage
      They require tons of money to continue research
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      In good company:
      "Under the deal, Vor Bio will issue 55.9 million common stock shares and corresponding warrants to buy an additional 69.8 million shares at a combined price of $0.99425 per share and warrant. The warrants, exercisable at $0.838 per share, might be used until 2031, hence perhaps adding $58.5 million in profits if completely used.

      New investor Reid Hoffman spearheaded the fundraising with major shareholder RA Capital Management, Vor Bio. As agreed upon, each will get board representation. Hoffman called the company's trem-cel therapy which targets acute myeloid leukemia using CRISpen/Cas9 technology a hopeful development in cancer treatment."

      https://en.wikipedia.org/wiki/Reid_Hoffman

      https://finance.yahoo.com/news/vor-biopharma-secures-55-6m-142740239.html?guccounter=1&guce_referrer=aHR0cHM6Ly9maW52aXouY29tLw&guce_referrer_sig=AQAAAG0tuNK9MvQB11zJKjsCQuEXY65q6qJMzVa2xMmGe_UPW73P3TlZrz53TlAto0KIOzFJ1VOTQl_6hH3osmqgEEGKEQk_aQUDk2rx8achcDajSgaiFx67nHkqOXSvZcVp8ESdlQrR50KKetBIcDD94B2WvRxwy_U_Dyng_1W8jD1d
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      close above 200??
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      Money goes where its treated best.... now imagine what the stock can do on actual data
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      not bad
      still looking for a VINC move! waiting for the unveil
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      GOOD stuff - remember traded at .8s last weeks

      Vor Bio will issue an aggregate of 55,871,260 shares of common stock and accompanying warrants to purchase an aggregate of 69,839,075 shares of common stock at a combined price of $0.99425 per share and accompanying warrants. The warrants will have a per share exercise price of $0.838 and may be exercised at any time on or after the closing date and through the seventh anniversary of the closing date
      https://www.globenewswire.com/news-release/2024/12/27/3002259/0/en/Vor-Bio-Announces-55-6-Million-Private-Placement.html
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      beam me up scotty
      👍️0
      PonkenPlonken PonkenPlonken 4 months ago
      readying here
      👍️0
      PonkenPlonken PonkenPlonken 5 months ago
      VINC type move coming
      👍️0
      PonkenPlonken PonkenPlonken 5 months ago
      super super undervalued. Sid Mukherjee - gifted founder. Couple with recent clinical validation...
      Problem in AML is not the drugs efficacy rather the possibility to handle the drug. They might just fix that.
      👍️0
      PonkenPlonken PonkenPlonken 5 months ago
      good dip buy
      👍️0
      PonkenPlonken PonkenPlonken 7 months ago
      The buyers of all these shares arent going anywhere. Waiting for it to unfold.
      All the traders didnt understand this prudent PR? You dont need fluffy if you have the real deal
      👍️0
      PonkenPlonken PonkenPlonken 7 months ago
      remember this was founded to heal patients, not retire the management. This is a mission by the brilliant founder and the $$ will come as a by product of things being very right.
      👍️0
      PonkenPlonken PonkenPlonken 7 months ago
      Helps where CAR T cant in AML. Its about giving MORE of the drugs that heal..... they work but the body cant handle them. With VOR, it can.

      People might just start realizing how huge the possibilities for this are.... GIVEN: r/r AML makes up 40-50% in younger patients and the great majority of elderly patients.
      Now experiment with the 20bn TAM for r/r AML and some funny numbers start popping up.
      Look at the founder... hes onto something.

      the actual data will speak soon. The investigator is ultra optimistic.... he likely saw more.
      👍️0
      glenn1919 glenn1919 7 months ago
      VOR................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 10 months ago
      VOR new 52 week low
      👍️0
      Monksdream Monksdream 10 months ago
      VOR new 52 week low
      👍️0
      PonkenPlonken PonkenPlonken 10 months ago
      Sid Mukherjee saw the potential in Saar Gills and Carl Junes approach and funded VOR==== shielding the right cells and attacking the cancer. For simplicity, it could be summed up as bottom up selectivity.................
      Very different from all the other CAR T stuff out there that is pretty much top-down-y. And in my opinion, top down systems dont work.
      5am and RA certainly think so. Will go back to the IPO price and then some is my bet.
      👍️0
      Monksdream Monksdream 10 months ago
      GNPX new 52 week low

      👍️0
      PonkenPlonken PonkenPlonken 10 months ago
      Im starting to think someone just buys them out.
      Interesting action yesterday.
      👍️0
      Monksdream Monksdream 10 months ago
      VOR new 52 week low
      👍️0
      Monksdream Monksdream 11 months ago
      VOR new 52 week low
      👍️0
      PonkenPlonken PonkenPlonken 11 months ago
      elevated volume for quite some time now.
      👍️0
      PonkenPlonken PonkenPlonken 12 months ago
      https://en.wikipedia.org/wiki/Siddhartha_Mukherjee founder is a smart man. They can do Car T without the tox.
      👍️0
      Monksdream Monksdream 1 year ago
      VORBunder $2
      👍️0
      glenn1919 glenn1919 1 year ago
      VOR.....................................https://stockcharts.com/h-sc/ui?s=VOR&p=W&b=5&g=0&id=p86431144783
      👍️0

      Your Recent History

      NASDAQ
      VOR
      Vor Biopharma
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads